From Concept to Cure: Using AAV in Gene Therapy


Application of analytical technologies to streamline AAV production, quality control, and therapeutic development


Recombinant adeno associated vectors (rAAVs) are gaining popularity for treating human genetic diseases. However, validating rAAV assembly and production at each workflow step creates barriers for bringing the technology to the clinic in a cost-effective manner.

This eBook serves as a comprehensive resource designed to help researchers streamline quality control steps to evaluate rAAV yield, purity, and potency to make these therapeutics safer and cost-effective.

 

Key Takeaways

1. Vector Safety & Immune Response Considerations

  • Safety and toxicity remain primary concerns with the use of AAVs due to potential immune responses or off-target effects at high therapeutic doses.

2. Comprehensive Viral Characterization (Viral Titer & Genome Integrity)

  • Rigorous characterization during production—including accurate measurement of physical titer (viral particles) and functional titer (vector genome count)—is essential.

3. Monitoring Full vs. Empty Capsid Ratios

  • AAV manufacturing inherently produces a mixture of full capsids (containing the target therapeutic gene), empty capsids (lacking DNA), and partially filled capsids, which can trigger an unnecessary immune response and cytotoxicity in patients.

4. Viral Capsid Purity, Identity, and Protein Ratios

  • Deviations in capsid protein ratios or the presence of impurities (like host cell proteins) can alter capsid assembly, reduce viral stability, alter tissue tropism, or cause product batch batch-to-batch inconsistency.

5. Overcoming Manufacturing Hurdles & Ensuring Quality Control (GMP Compliance)

  • Transitioning an AAV candidate from bench research to commercial scale requires robust quality control (QC) workflows, ensuring the removal of residual host cell DNA, mycoplasma, and contaminants under Good Manufacturing Practice (GMP) guidelines.

Download the eBook and learn how techniques like Droplet Digital™ PCR (ddPCR) are helping to streamline AAV production, increase quality control, and drive therapeutic development workflows, from bench research to scale up to manufacturing.


DOWNLOAD THIS EBOOK TO LEARN MORE

Become a member and enjoy exclusive benefits

Create an account now for exclusive benefits, personalized recommendations, and seamless order tracking. Elevate your lab experience today!